AIC
DRNA

AWM Investment Company’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

AWM Investment Company’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-80,000
Closed -$657K – 106
2015
Q3 		$657K Hold
80,000
– – 0.13% 100
2015
Q2 		$1.12M Hold
80,000
– – 0.16% 95
2015
Q1 		$1.92M Hold
80,000
– – 0.27% 88
2014
Q4 		$1.32M Buy
+80,000
New +$923K 0.18% 101

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AWM Investment Company's DRNA Position: Q4 2015 in Review

AWM Investment Company sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2015, closing a stake of 80,000 shares — an estimated $657K sold.

AWM Investment Company first reported a position in DRNA in Q4 2014 and held it in 4 quarters. The position peaked at $1.92M in Q1 2015. 58 funds tracked by Wall St. Rank hold DRNA as of Q4 2015.

  • AWM Investment Company reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • AWM Investment Company sold 80,000 Dicerna Pharmaceuticals, Inc. shares in Q4 2015, an estimated $657K.
  • AWM Investment Company first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • AWM Investment Company's Dicerna Pharmaceuticals, Inc. position peaked at $1.92M in Q1 2015.
  • 58 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2015.

Based on AWM Investment Company's 13F filing for Q4 2015, filed 8 Feb 2016.